Articles

Results 1 to 5 of 13
Most popular |Most recent


When Saying More Gets You Less: The Federal Circuit Affirms That Superfluous Prosecution Arguments Can Limit Doctrine of Equivalents Infringement

USA - July 30 2019 Prosecution history estoppel can bar a claim of patent infringement under the doctrine of equivalents where a patentee’s statements lead a competitor…

Devon C. Beane.

Federal Circuit Instructs the PTAB on Written Description in University Interference Proceeding

USA - July 13 2017 On June 27, 2017, the U.S. Federal Circuit vacated and remanded the Patent Trial and Appeal Board’s (Board) decisions in three interference…

Jenna Bruce.

Sandoz v. Amgen - Biosimilars at the U.S. Supreme Court

USA - July 6 2017 The U.S. Supreme Court unanimously decided Sandoz Inc., v. Amgen Inc., on Monday June 12, 2017, construing the Biologics Price Competition and…

Kenneth C. Liao, Margaux L. Nair.

Where Can Hatch-Waxman and BPCIA Cases Stick After TC Heartland LLC v. Kraft Foods Group Brands LLC?

USA - June 9 2017 Hatch-Waxman litigators are accustomed to cases with multiple generic drug company defendants. Brand drug company plaintiffs often sue multiple…

Elizabeth J. Weiskopf, Kenneth C. Liao, Theodore J. Angelis.

Remicade® Update: Passing Up Your Chance to Dance Can Increase Damages

USA - June 8 2017 On March 2, 2017, U.S. District Court Judge Mark Wolf provided guidance for determining the appropriate measure of damages in Janssen Biotech, Inc. v…

Harold Storey, Kelly A. Plummer, Ph.D., Theodore J. Angelis.